Atlas Trials

Neurodevelopmental Effects of Antiseizure Medications (NEAM) - UG3 Phase

Clinical trial NCT05364853 · WITHDRAWN

Trial details

NCT number
NCT05364853
Sponsor
Stanford University
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Epilepsy
Start date
2024-04-01
Primary completion
2026-03-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.